 II. To correlate clinical outcomes with the kinetics of reduction in promyelocytic leukemia PMLretinoic acid receptor alpha RARalpha transcript level by quantitative reverse transcription-polymerase chain reaction RT-PCR RQ-PCR in bone marrow and peripheral blood samples from diagnosis to time points during therapy. 